{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:24:12Z","timestamp":1761171852835,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.farma.2010.01.004","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T10:04:25Z","timestamp":1274954665000},"page":"188-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adecuaci\u00f3n de la prescripci\u00f3n al alta hospitalaria en pacientes con enfermedad pulmonar obstructiva cr\u00f3nica"],"prefix":"10.1016","volume":"34","author":[{"given":"B.","family":"Garc\u00eda Robredo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Calleja Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.I.","family":"Luque Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ubago P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Faus D\u00e1der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2010.01.004_bib1","first-page":"260","article-title":"Miembros del Comit\u00e9. est\u00e1ndares para el diagn\u00f3stico y tratamiento de pacientes con EPOC: resumen del position paper elaborado por el grupo de trabajo ATS\/ERS","volume":"5","author":"Celli","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.farma.2010.01.004_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0300-2896(01)75074-0","article-title":"Gu\u00eda cl\u00ednica para el diagn\u00f3stico y el tratamiento de la enfermedad pulmonar obstructiva cr\u00f3nica","volume":"37","author":"Barber\u00e1","year":"2001","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.farma.2010.01.004_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1157\/13093470","article-title":"Enfermedad pulmonar obstructiva cr\u00f3nica, un problema de salud p\u00fablica","volume":"206","author":"De la Fuente Cid","year":"2006","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.farma.2010.01.004_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0300-2896(15)30272-6","article-title":"Estudio IBERPOC en Espa\u00f1a: prevalencia de s\u00edntomas respiratorios habituales y de limitaci\u00f3n cr\u00f3nica al flujo a\u00e9reo","volume":"35","author":"Sobradillo","year":"1999","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.farma.2010.01.004_bib5","first-page":"1","article-title":"Chronic obstructive pulmonary disease surveillance- United States, 1971\u20132000","volume":"51","author":"Mannino","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.farma.2010.01.004_bib6","unstructured":"Centro Andaluz de Informaci\u00f3n de Medicamentos. EPOC: Tratamiento farmacol\u00f3gico. Monograf\u00edas. Granada: Escuela Andaluza de Salud P\u00fablica. CADIME; 2004."},{"key":"10.1016\/j.farma.2010.01.004_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1157\/13091647","article-title":"Etiolog\u00eda bacteriana de la agudizaci\u00f3n de la bronquitis cr\u00f3nica en atenci\u00f3n primaria","volume":"42","author":"Llor","year":"2006","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.farma.2010.01.004_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000067462","article-title":"Factors associated with increased risk of admission in a cohort of ambulatory COPD patients: A multiple logistic regression analysis","volume":"67","author":"Miravitlles","year":"2000","journal-title":"Respiration"},{"key":"10.1016\/j.farma.2010.01.004_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0212-6567(01)78899-3","article-title":"Gu\u00edas de pr\u00e1ctica cl\u00ednica en Internet","volume":"28","author":"Garc\u00eda Guti\u00e9rrez","year":"2001","journal-title":"Aten Primaria"},{"key":"10.1016\/j.farma.2010.01.004_bib10","first-page":"1","article-title":"Qu\u00e9 son las Gu\u00edas de Pr\u00e1ctica Cl\u00ednica","volume":"7","author":"Casariego Vales","year":"2007","journal-title":"Gu\u00edas Cl\u00ednicas"},{"key":"10.1016\/j.farma.2010.01.004_bib11","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Guide to COPD Diagnosis, Management, and Prevention. GOLD; 2006. Disponible en: http:\/\/www.goldcopd.com."},{"key":"10.1016\/j.farma.2010.01.004_bib12","first-page":"340","article-title":"Calidad de la asistencia hospitalaria y riesgo de reingreso precoz en la exacerbaci\u00f3n aguda de la EPOC","volume":"20","author":"Jim\u00e9nez Puente","year":"2003","journal-title":"An Med Interna"},{"key":"10.1016\/j.farma.2010.01.004_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0300-2896(03)75437-4","article-title":"Descripci\u00f3n de una muestra de pacientes con enfermedad pulmonar obstructiva cr\u00f3nica atendidos en las consultas del \u00e1rea de neumolog\u00eda dependientes de un hospital","volume":"39","author":"Esteban","year":"2003","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.farma.2010.01.004_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0300-2896(01)78818-7","article-title":"Impacto asistencial hospitalario de la EPOC. Peso espec\u00edfico del paciente con EPOC de alto consumo sanitario","volume":"37","author":"Soler","year":"2001","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.farma.2010.01.004_bib15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/09031936.01.00213701","article-title":"Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease","volume":"18","author":"Roche","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.farma.2010.01.004_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1183\/09031936.02.01302001","article-title":"Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease","volume":"20","author":"Miratvilles","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.farma.2010.01.004_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0300-2896(03)75361-7","article-title":"Tratamiento farmacol\u00f3gico de la EPOC en dos niveles asistenciales. Grado de adecuaci\u00f3n a las normativas recomendadas","volume":"39","author":"De Miguel D\u00edez","year":"2003","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.farma.2010.01.004_bib18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.rmed.2004.03.018","article-title":"Knowledge of guidelines for the management of COPD: a survey of primary care physicians","volume":"98","author":"Rutschman","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.farma.2010.01.004_bib19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.farma.2010.01.004_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001288.pub3","article-title":"Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","volume":"1","author":"Walters","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.farma.2010.01.004_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bmj.333.7558.87","article-title":"ABC of chronic obstructive pulmonary disease: Acute exacerbations","volume":"333","author":"Currie","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.farma.2010.01.004_bib22","unstructured":"Carratal\u00e1 Fern\u00e1ndez J, Navas Elorza E, San Juan R, Soriano F, Rodr\u00edguez Cerrato V. Gu\u00eda de recomendaciones en la Terapia Secuencial Antibi\u00f3tica. Gu\u00edas Cl\u00ednicas SEIMC. Aguado JM, Fort\u00fan J; 2006."},{"key":"10.1016\/j.farma.2010.01.004_bib23","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.farma.2010.01.004_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/thorax.58.2.100","article-title":"Risk factors of readmission to hospital for a COPD exacerbation: a prospective study","volume":"58","author":"Garc\u00eda-Aymerich","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.farma.2010.01.004_bib25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1157\/13112967","article-title":"Factores pron\u00f3sticos en la EPOC","volume":"43","author":"Soler Catalu\u00f1a","year":"2007","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.farma.2010.01.004_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634310001261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634310001261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:15:34Z","timestamp":1761106534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634310001261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1130634310001261"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2010.01.004","relation":{},"ISSN":["1130-6343"],"issn-type":[{"type":"print","value":"1130-6343"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adecuaci\u00f3n de la prescripci\u00f3n al alta hospitalaria en pacientes con enfermedad pulmonar obstructiva cr\u00f3nica","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2010.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 SEFH. Published by Elsevier Espa\u00f1a S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}